Search research articles
Contact Us
Filters
Showing results (111-120 of 134) with videos related to
Page
of 14
Sort By:
British Journal of Haematology
|
July 18, 2015
Optimizing the management of patients with spinal myeloma disease
Sean Molloy, Maggie Lai, Guy Pratt, et al.
Haematologica
|
April 5, 2015
Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants
Angelo Agathanggelou, Victoria J Weston, Tracey Perry, et al.
Haematologica
|
January 18, 2020
Low-dose Btk inhibitors selectively block platelet activation by CLEC-2
Phillip L R Nicolson, Sophie H Nock, Joshua Hinds, et al.
The Lancet. Oncology
|
November 1, 2019
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
Mark T Drayson, Stella Bowcock, Tim Planche, et al.
Insights Into Imaging
|
October 15, 2023
Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study
Sam Keaveney, Alina Dragan, Mihaela Rata, et al.
British Journal of Haematology
|
February 8, 2019
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial
Gordon Cook, Kara-Louise Royle, Sheila O'Connor, et al.
Science Translational Medicine
|
September 20, 2013
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia
Mark Cobbold, Hugo De La Peña, Andrew Norris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing
Marina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.
American Journal of Hematology
|
March 3, 2023
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing
Suzanne O Arulogun, Duncan Brian, Harshita Goradia, et al.
BMJ Open
|
November 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
Kara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 134) with videos related to
Sort By:
Page
of 14
British Journal of Haematology
|
July 18, 2015
Optimizing the management of patients with spinal myeloma disease
Sean Molloy, Maggie Lai, Guy Pratt, et al.
Haematologica
|
April 5, 2015
Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants
Angelo Agathanggelou, Victoria J Weston, Tracey Perry, et al.
Haematologica
|
January 18, 2020
Low-dose Btk inhibitors selectively block platelet activation by CLEC-2
Phillip L R Nicolson, Sophie H Nock, Joshua Hinds, et al.
The Lancet. Oncology
|
November 1, 2019
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
Mark T Drayson, Stella Bowcock, Tim Planche, et al.
Insights Into Imaging
|
October 15, 2023
Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study
Sam Keaveney, Alina Dragan, Mihaela Rata, et al.
British Journal of Haematology
|
February 8, 2019
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial
Gordon Cook, Kara-Louise Royle, Sheila O'Connor, et al.
Science Translational Medicine
|
September 20, 2013
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia
Mark Cobbold, Hugo De La Peña, Andrew Norris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing
Marina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.
American Journal of Hematology
|
March 3, 2023
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing
Suzanne O Arulogun, Duncan Brian, Harshita Goradia, et al.
BMJ Open
|
November 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
Kara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, et al.
Page
of 14